Literature DB >> 21755060

Torsadogenic Drug-induced Increased Short-term Variability of JT-area.

Xiao Jie1, Blanca Rodriguez, Esther Pueyo.   

Abstract

Increased beat-to-beat variability of repolarization (BVR) has been suggested to indicate increased susceptibility to drug-induced arrhythmia. This study aimed to characterize BVR in patients before and after administration of sotalol, a torsadogenic antiarrhythmic drug, in the search for new biomarkers of proarrhythmic risk. ECG Recordings pre and post sotalol injection in two groups of patients (with and without history of drug-induced torsades de pointes) were obtained from THEW. ECG wave detection and delineation were performed via dyadic wavelet transform. BVR was evaluated by short-term variability (STV) of QTc interval and JT area. In both groups, sotalol resulted in significant increase in STV of JT area, while no significant change occurred in STV of QTc interval. Thus, STV of JT area, as a measure of BVR, has the potential to be a biomarker for drug toxicity.

Entities:  

Year:  2010        PMID: 21755060      PMCID: PMC3133449     

Source DB:  PubMed          Journal:  Comput Cardiol (2010)        ISSN: 2325-887X


  13 in total

1.  Beat-to-Beat repolarization variability in LQTS patients with the SCN5A sodium channel gene mutation.

Authors:  J P Couderc; W Zareba; L Burattini; A J Moss
Journal:  Pacing Clin Electrophysiol       Date:  1999-11       Impact factor: 1.976

2.  Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic.

Authors:  L M Hondeghem; L Carlsson; G Duker
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

3.  A wavelet-based ECG delineator: evaluation on standard databases.

Authors:  Juan Pablo Martínez; Rute Almeida; Salvador Olmos; Ana Paula Rocha; Pablo Laguna
Journal:  IEEE Trans Biomed Eng       Date:  2004-04       Impact factor: 4.538

4.  Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes.

Authors:  Morten B Thomsen; Paul G A Volders; Jet D M Beekman; Jørgen Matz; Marc A Vos
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

5.  Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy.

Authors:  R D Berger; E K Kasper; K L Baughman; E Marban; H Calkins; G F Tomaselli
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

Review 6.  Refining detection of drug-induced proarrhythmia: QT interval and TRIaD.

Authors:  Rashmi R Shah; Luc M Hondeghem
Journal:  Heart Rhythm       Date:  2005-07       Impact factor: 6.343

7.  The JT-area indicates dispersion of repolarization in dogs with atrioventricular block.

Authors:  Jurren M van Opstal; S Cora Verduyn; Stephan K G Winckels; Hendrik M Leerssen; Jet D M Leunissen; Hein J J Wellens; Marc A Vos
Journal:  J Interv Card Electrophysiol       Date:  2002-06       Impact factor: 1.900

8.  An evaluation of ECG leads used to assess QT prolongation.

Authors:  Tsuneaki Sadanaga; Fumiko Sadanaga; Hiroshi Yao; Masatoshi Fujishima
Journal:  Cardiology       Date:  2006-02-01       Impact factor: 1.869

9.  Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.

Authors:  Jean-Philippe Couderc; Stefan Kaab; Martin Hinterseer; Scott McNitt; Xiaojuan Xia; Anthony Fossa; Britt M Beckmann; Slava Polonsky; Wojciech Zareba
Journal:  J Clin Pharmacol       Date:  2008-10-28       Impact factor: 3.126

10.  Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs.

Authors:  Morten B Thomsen; S Cora Verduyn; Milan Stengl; Jet D M Beekman; Geert de Pater; Jurren van Opstal; Paul G A Volders; Marc A Vos
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.